signed an agreement with
that covers the marketing of dermal filler products for treating wrinkles.
Under the agreement, Genzyme will develop the fillers. The first product is expected to launch internationally in early 2007, and another product should be available later next year.
Additionally, the two companies will collaborate to develop a longer-lasting hyaluronic-acid dermal filler, Mentor said Monday.
"With Genzyme's extensive history in
hyaluronic acid development and manufacturing, Mentor has created a partnership that will allow its facial aesthetics pipeline to expand significantly," the company said in a press release. "All of the products will be introduced into Mentor's current distribution network, maximizing the revenue opportunity."
Specific terms of the agreement were not disclosed. Mentor was up 0.8% to $47.69.